JP Patent

JP5793423B2 — 急性冠症候群の治療のためのＬＮＡＡｐｏＢアンチセンスオリゴマーの使用

Assigned to Roche Innovation Center Copenhagen AS · Expires 2015-10-14 · 11y expired

What this patent protects

Patent listed against Onpattro.

Drugs covered by this patent

Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals

Patent Metadata

Patent number: JP5793423B2
Jurisdiction: JP
Classification: —
Expires: 2015-10-14
Drug substance claim: No
Drug product claim: No
Assignee: Roche Innovation Center Copenhagen AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.